Journal List > Tuberc Respir Dis > v.66(3) > 1001343

TOOLS
Kim: Cardovascular Impacts of Sleep-disordered Breathing
Review Article
Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases 2009; 66(3): 173-177.

Published online: 31 March 2009

DOI: https://doi.org/10.4046/trd.2009.66.3.173

Cardovascular Impacts of Sleep-disordered Breathing

Woo Sung Kim, M.D., Ph.D.

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Address for correspondence: Woo Sung Kim, M.D., Ph.D. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Poongnap-dong, Songpa-gu, Seoul 138-736, Korea. Phone: 82-2-3010-3133, Fax: 82-2-3010-3968, wskim2@amc.seoul.kr

Received 13 November 2008       Accepted 28 January 2009

Copyright©2009. The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Figures and Tables

Figure 1
Association between OSA and cardiovascular disease. OSA: obstructive sleep apnea; CHF: congestive heart failure; CAD: coronary artery disease; LV: left ventricular.
trd-66-173-g001
Figure 2
Long-term risk for cardiovascular events according to the presence of OSA and treatment with CPAP. OSA: obstructive sleep apnea; OSAH: OSA/hypopnea; CPAP: continuous positive airway pressure.
trd-66-173-g002
Figure 3
Prognostic value of central sleep apnea in patients with heart failure. AHI: apnea-hypopnea index.
trd-66-173-g003

References

1. Golbin JM, Somers VK, Caples SM. Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc. 2008. 5:200–206.
2. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease. J Am Coll Cardiol. 2008. 52:686–717.
3. Phillips B. Sleep-disordered breathing and cardiovascular disease. Sleep Med Rev. 2005. 9:131–140.
4. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007. 29:156–178.
5. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension: a population-based study. Ann Intern Med. 1994. 120:382–388.
6. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med. 2006. 173:910–916.
7. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005. 365:1046–1053.
8. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003. 348:1233–1241.
9. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004. 169:361–366.
10. Smith LA, Vennelle M, Gardner RS, McDonagh TA, Denvir MA, Douglas NJ, et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J. 2007. 28:1221–1227.
11. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation. 1999. 99:1435–1440.
12. Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005. 353:2025–2033.
TOOLS
Similar articles